Annual report pursuant to Section 13 and 15(d)

Intangible Assets (Details)

v3.20.4
Intangible Assets (Details) - USD ($)
Sep. 30, 2020
Sep. 30, 2019
Intangible Assets    
Clinical trial data $ 250,000 $ 250,000
Accumulated Amortization and impairment (250,000) (104,167)
Intangible assets, net $ 0 $ 145,833